The kallikrein panel, consisting of the endosomal secreted proteins total PSA, free PSA, intact PSA, and human kallikrein-2, is the current gold standard screening approach for prostate cancer but was originally only proposed to be used for monitoring [193]. Here, KLK2 is linked to prostate cancer.